Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Koncept Analytics | PRODUCT CODE: 1092283

Cover Image

PUBLISHER: Koncept Analytics | PRODUCT CODE: 1092283

Global Peptide Therapeutics Market (by Type, Synthesis Technology, Manufacturing Type, Application & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

PUBLISHED:
PAGES: 89 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1600
PDF (Corporate User License)
USD 2000

Add to Cart

The global peptide therapeutics market is expected to record a value of US$44.43 billion in 2026, progressing at a CAGR of 6.95%, over the period 2022-2026. The factors such as surging prevalence of cancer, rising healthcare expenditure, growing incidence of metabolic disorders, increasing geriatric population and accelerating number of approved peptide-based therapeutic drugs. However, the market growth would be challenged by availability of generic or biosimilar peptide therapeutic drugs, high cost of developing drugs and stringent regulatory requirements and production complexity of peptides. The market is anticipated to experience certain trends like expanding volume of peptides driven by generics, rapid adoption of outsourced peptide API and rising investments in research and development of novel drugs.

The global peptide therapeutics market can be segmented on the basis of type, synthesis technology, manufacturing type and application. Based on type, the market can be bifurcated into innovative and generic. According to synthesis technology, the market can be categorized into Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS) and Hybrid Technology. Whereas, on the basis of manufacturing type, the market can be divided outsourced and in-house. In terms of application, the global peptide therapeutics market can be split into chemotherapy, gastroenterology, analgesia, diabetes, pediatric & neonatology and other applications.

The fastest growing regional market is North America due to increasing research and development activities for the development of innovative peptide therapeutics and improvements in healthcare infrastructure coupled with growing prescription of peptide therapeutics on account of high presence of a large number of patients with chronic diseases such as diabetes and cancer.

Scope of the report:

  • The report provides a comprehensive analysis of the global peptide therapeutics market segmented on the basis of type, synthesis technology, manufacturing type and application region.
  • The major regional and country markets (North America, Europe, Middle East & Africa, Asia Pacific and Latin America) have been analyzed.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The company profiles of leading players (Novartis International AG, GlaxoSmithKline PLC, Bristol Myers Squibb Co., Amgen Inc., Eli Lilly and Company and PolyPeptide Group AG) are also presented in detail.

Key Target Audience:

  • Peptide Manufacturers, Suppliers & Distributors
  • Pharmaceutical, Biopharmaceutical & Biotechnological Companies
  • Research and Development (R&D) Organizations
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1. Introduction
  • 1.2. Manufacturing Process of Peptides
  • 1.3. Classification of Peptides
  • 1.4. Functional Classification of Therapeutic Peptides & Proteins
  • 1.5. Examples of Peptide-based Drugs
  • 1.6. Advantages and Disadvantages of Therapeutic Peptides
  • 1.7. Source or Chemical Nature of Early Peptides

2. Impact of COVID-19

  • 2.1. Adoption of Peptides in COVID-19 Related Research
  • 2.2. Disruptions in Clinical Trials

3. Global Market Analysis

  • 3.1. Global Peptide Therapeutics Market by Value
  • 3.2. Global Peptide Therapeutics Market Forecast by Value
  • 3.3. Global Peptide Therapeutics Market by Type
    • 3.3.1. Global Innovative Peptide Therapeutics Market by Value
    • 3.3.2. Global Innovative Peptide Therapeutics Market Forecast by Value
    • 3.3.3. Global Generic Peptide Therapeutics Market by Value
    • 3.3.4. Global Generic Peptide Therapeutics Market Forecast by Value
  • 3.4. Global Peptide Therapeutics Market by Synthesis Technology
    • 3.4.1. Global Solid Phase Peptide Synthesis Therapeutics Market by Value
    • 3.4.2. Global Solid Phase Peptide Synthesis Therapeutics Market Forecast by Value
    • 3.4.3. Global Liquid Phase Peptide Synthesis Therapeutics Market by Value
    • 3.4.4. Global Liquid Phase Peptide Synthesis Therapeutics Market Forecast by Value
    • 3.4.5. Global Hybrid Technology Synthesis Therapeutics Market by Value
    • 3.4.6. Global Hybrid Technology Synthesis Therapeutics Market Forecast by Value
  • 3.5. Global Peptide Therapeutics Market by Manufacturing Type
    • 3.5.1. Global Outsourced Peptide Therapeutics Market Forecast by Value
    • 3.5.2. Global In-house Peptide Therapeutics Market Forecast by Value
  • 3.6. Global Peptide Therapeutics Market by Application
    • 3.6.1. Global Metabolic Disorders Peptide Therapeutics Market by Value
    • 3.6.2. Global Metabolic Disorders Peptide Therapeutics Market Forecast by Value
    • 3.6.3. Global Oncology Peptide Therapeutics Market by Value
    • 3.6.4. Global Oncology Peptide Therapeutics Market Forecast by Value
    • 3.6.5. Global Gastrointestinal Disorders Peptide Therapeutics Market by Value
    • 3.6.6. Global Gastrointestinal Disorders Peptide Therapeutics Market Forecast by Value
    • 3.6.7. Global Cardiovascular Disorders Peptide Therapeutics Market by Value
    • 3.6.8. Global Cardiovascular Disorders Peptide Therapeutics Market Forecast by Value
    • 3.6.9. Global Neurological Disorders Peptide Therapeutics Market by Value
    • 3.6.10. Global Neurological Disorders Peptide Therapeutics Market Forecast by Value
  • 3.7. Global Peptide Therapeutics Market by Region

4. Regional Market Analysis

  • 4.1. North America
    • 4.1.1. North America Peptide Therapeutics Market by Value
    • 4.1.2. North America Peptide Therapeutics Market Forecast by Value
    • 4.1.3. The U.S. Peptide Therapeutics Market Forecast by Value
    • 4.1.4. The U.S. Peptide Therapeutics Market Forecast by Type
  • 4.2. Europe, Middle East & Africa
    • 4.2.1. Europe, Middle East & Africa Peptide Therapeutics Market by Value
    • 4.2.2. Europe, Middle East & Africa Peptide Therapeutics Market Forecast by Value
  • 4.3. Asia Pacific
    • 4.3.1. Asia Pacific Peptide Therapeutics Market by Value
    • 4.3.2. Asia Pacific Peptide Therapeutics Market Forecast by Value
  • 4.4. Latin America
    • 4.4.1. Latin America Peptide Therapeutics Market by Value
    • 4.4.2. Latin America Peptide Therapeutics Market Forecast by Value

5. Market Dynamics

  • 5.1. Growth Drivers
    • 5.1.1. Surging Prevalence of Cancer
    • 5.1.2. Rising Healthcare Expenditure
    • 5.1.3. Growing Incidence of Metabolic Disorders
    • 5.1.4. Increasing Geriatric Population
    • 5.1.5. Accelerating Number of Approved Peptide-based Therapeutic Drugs
  • 5.2. Key Trends and Developments
    • 5.2.1. Expanding Volume of Peptides driven by Generics
    • 5.2.2. Rapid Adoption of Outsourced Peptide API
    • 5.2.3. Rising Investments in Research and Development of Novel Drugs
  • 5.3. Challenges
    • 5.3.1. Availability of Generic or Biosimilar Peptide Therapeutic Drugs
    • 5.3.2. High Cost of Developing Drugs and Stringent Regulatory Requirements
    • 5.3.3. Production Complexity of Peptides

6. Company Profiles

  • 6.1. Novartis International AG
    • 6.1.1. Business Overview
  • 6.2. GlaxoSmithKline PLC
    • 6.2.1. Business Overview
  • 6.3. Bristol Myers Squibb Co.
    • 6.3.1. Business Overview
  • 6.4. Amgen Inc.
    • 6.4.1. Business Overview
  • 6.5. Eli Lilly and Company
    • 6.5.1. Business Overview
  • 6.6. PolyPeptide Group AG
    • 6.6.1. Business Overview

List of Figures

  • Manufacturing Process of Peptides
  • Classification of Peptides
  • Functional Classification of Therapeutic Peptides & Proteins
  • Advantages and Disadvantages of Therapeutic Peptides
  • Global Most Affected Clinical Trials by Therapy Area (2020)
  • Global Peptide Therapeutics Market by Value (2017-2021)
  • Global Peptide Therapeutics Market Forecast by Value (2022-2026)
  • Global Peptide Therapeutics Market by Type (2021)
  • Global Innovative Peptide Therapeutics Market by Value (2017-2021)
  • Global Innovative Peptide Therapeutics Market Forecast by Value (2022-2026)
  • Global Generic Peptide Therapeutics Market by Value (2017-2021)
  • Global Generic Peptide Therapeutics Market Forecast by Value (2022-2026)
  • Global Peptide Therapeutics Market by Synthesis Technology (2021)
  • Global Solid Phase Peptide Synthesis Therapeutics Market by Value (2017-2021)
  • Global Solid Phase Peptide Synthesis Therapeutics Market Forecast by Value (2022-2026)
  • Global Liquid Phase Peptide Synthesis Therapeutics Market by Value (2017-2021)
  • Global Liquid Phase Peptide Synthesis Therapeutics Market Forecast by Value (2022-2026)
  • Global Hybrid Technology Synthesis Therapeutics Market by Value (2017-2021)
  • Global Hybrid Technology Synthesis Therapeutics Market Forecast by Value (2022-2026)
  • Global Peptide Therapeutics Market by Manufacturing Type (2021)
  • Global Outsourced Peptide Therapeutics Market Forecast by Value (2021-2026)
  • Global In-house Peptide Therapeutics Market Forecast by Value (2021-2026)
  • Global Peptide Therapeutics Market by Application (2021)
  • Global Metabolic Disorders Peptide Therapeutics Market by Value (2017-2021)
  • Global Metabolic Disorders Peptide Therapeutics Market Forecast by Value (2022-2026)
  • Global Oncology Peptide Therapeutics Market by Value (2017-2021)
  • Global Oncology Peptide Therapeutics Market Forecast by Value (2022-2026)
  • Global Gastrointestinal Disorders Peptide Therapeutics Market by Value (2017-2021)
  • Global Gastrointestinal Disorders Peptide Therapeutics Market Forecast by Value (2022-2026)
  • Global Cardiovascular Disorders Peptide Therapeutics Market by Value (2017-2021)
  • Global Cardiovascular Disorders Peptide Therapeutics Market Forecast by Value (2022-2026)
  • Global Neurological Disorders Peptide Therapeutics Market by Value (2017-2021)
  • Global Neurological Disorders Peptide Therapeutics Market Forecast by Value (2022-2026)
  • Global Peptide Therapeutics Market by Region (2021)
  • North America Peptide Therapeutics Market by Value (2017-2021)
  • North America Peptide Therapeutics Market Forecast by Value (2022-2026)
  • The U.S. Peptide Therapeutics Market Forecast by Value (2021-2026)
  • The U.S. Peptide Therapeutics Market by Type (2021-2026)
  • Europe, Middle East & Africa Peptide Therapeutics Market by Value (2017-2021)
  • Europe, Middle East & Africa Peptide Therapeutics Market Forecast by Value (2022-2026)
  • Asia Pacific Peptide Therapeutics Market by Value (2017-2021)
  • Asia Pacific Peptide Therapeutics Market Forecast by Value (2022-2026)
  • Latin America Peptide Therapeutics Market by Value (2017-2021)
  • Latin America Peptide Therapeutics Market Forecast by Value (2022-2026)
  • Global Cancer Prevalence (2018-2023)
  • Global Healthcare Expenditure Per Capita (2017-2021)
  • Global Diabetes Prevalence (2010-2045)
  • Global Population Ages 65 Years and Above (2017-2021)
  • Number of Approved/Launched Peptide Therapeutic Drugs Worldwide (2020-2025)
  • Global GLP-1 Market Development (2018-2027)
  • Global In-House vs. Outsourced Peptide API Market Development (2020-2025)
  • Global Spending on Pharmaceutical Research and Development (2018-2026)
  • Global Biosimilar Therapeutic Peptides Market (2020-2025)

List of Tables

  • Difference between Peptides, Small Molecules & Biologics
  • Examples of Peptide-based Drugs Available in the Market
  • Source or Chemical Nature of Early Peptides
  • Synthetic Peptides in Development of COVID-19 (2020)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!